设计,合成和活动评估的醇衍生物作为潜在的稳定剂p53 Y220C
Linquan Li1, Xi Gu2, Jingyi Meng3
1School of Chemical Engineering, Sichuan University of Science & Engineering, Zigong 643000, China; School of Pharmaceutical Science and Technology, Hangzhou Institute of Advanced Study, UCAS, Hangzhou 310024, China.
Bioorganic & medicinal chemistry letters
|March 8, 2025
概括
研究人员设计了新的化合物来稳定p53 Y220C突变,这是一个常见的致癌蛋白. 化合物C8-1b选择性地抑制了瘤细胞的生长,为癌症治疗提供了潜在的策略.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 在瘤学瘤学.
背景情况:
- 在人类癌症中,p53 Y220C突变很普遍.
- 这种突变导致蛋白质不稳定和功能丧失,促进瘤的发展.
研究的目的:
- 设计和合成针对p53 Y220C突变的新型化合物.
- 评估这些化合物的稳定作用和抗癌活性.
主要方法:
- 基于活性化合物C8.8的化合物合成.
- 蛋白质热转移试验用于测量热稳定性.
- 细胞活力测定以评估抗增殖效应.
- 分子对接和相互作用分析.
主要成果:
- 合成了8种化合物,其中C8-3b和C8-6具有与C8.8类似的活性.
- 化合物C8-1a,C8-1b和C8-2b增强了p53 Y220C的热稳定性 (ΔT: +1.0°C).
- C8-1b证明了具有p53 Y220C突变的瘤细胞的选择性抑制.
结论:
- 合成的化合物可以稳定p53 Y220C蛋白.
- 在p53 Y220C突变的癌症中,C8-1b显示出作为治疗的潜力.
- 这项工作为开发用于p53突变的小分子稳定剂提供了合理的基础.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K


